Catalyst Wire Dossier Catalyst Wire Dossier

23-valent pneumococcal polysaccharide vaccine (PPSV23)

Pneumococcal polysaccharide vaccine, 23-valent
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 23-valent pneumococcal polysaccharide vaccine (PPSV23), covering 2025-07-17 to 2025-07-17. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population

See pricing